Literature DB >> 17251824

Infectious scleritis after pars plana vitrectomy because of methicillin-resistant Staphylococcus aureus resistant to fourth-generation fluoroquinolones.

Vahid Feiz1, Daniel E Redline.   

Abstract

PURPOSE: To describe a case of infectious scleritis caused by methicillin-resistant Staphylococcus aureus (MRSA) after pars plana vitrectomy despite treatment with topical fourth-generation fluoroquinolones.
METHODS: Single interventional case report.
RESULTS: A 72-year-old man presented with scleral thinning and subconjunctival abscess 1 month after pars plana vitrectomy. Microbiological studies including cultures and antibiotic sensitivity were performed. Culture of the scleral abscess showed growth of MRSA resistant to fourth-generation fluoroquinolones and sensitive to vancomycin and erythromycin. Treatment with a combination of topical vancomycin and systemic erythromycin for 6 weeks resolved the infectious scleritis.
CONCLUSIONS: MRSA can be a cause of infectious scleritis after ocular surgery without a clear source despite surgical prophylaxis with topical fourth-generation fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251824     DOI: 10.1097/01.ico.0000248383.09272.ee

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

1.  [Multiresistant bacteria in ophthalmology].

Authors:  T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  Management and outcome of microbial anterior scleritis.

Authors:  Matthew A Cunningham; Jamie K Alexander; Alice Y Matoba; Dan B Jones; Kirk R Wilhemus
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

3.  Microbial keratitis and the selection of topical antimicrobials.

Authors:  Stephen Kaye
Journal:  BMJ Open Ophthalmol       Date:  2017-05-24

Review 4.  Scleritis: Differentiating infectious from non-infectious entities.

Authors:  Somasheila I Murthy; Swapnali Sabhapandit; S Balamurugan; Pranesh Subramaniam; Maite Sainz-de-la-Maza; Manisha Agarwal; Carlos Parvesio
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.